Fedenia Advisers’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.95K Buy
+164
New +$4.29K ﹤0.01% 404
2025
Q1
Sell
-1,840
Closed -$48.8K 333
2024
Q4
$48.8K Buy
+1,840
New +$49.9K 0.03% 253

Other funds holding PFE

Fedenia Advisers's PFE Position: Q2 2026 in Review

Fedenia Advisers opened a new position in Pfizer (PFE) in Q2 2026: 164 shares worth $3.95K. The stake represents ﹤0.01% of the portfolio and ranks #404 among its holdings. This is a return to the name: Fedenia Advisers previously reported a position in PFE as recently as Q4 2024.

Fedenia Advisers first reported a position in PFE in Q4 2024 and has held it in 2 quarters since. The position peaked at $48.8K in Q4 2024. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fedenia Advisers held 164 shares of Pfizer worth $3.95K as of Q2 2026.
  • Pfizer was a new Fedenia Advisers position in Q2 2026.
  • Pfizer made up ﹤0.01% of Fedenia Advisers's portfolio in Q2 2026, its #404 holding.
  • Fedenia Advisers first reported a position in Pfizer in Q4 2024 and has held it in 2 quarters since.
  • Fedenia Advisers's Pfizer position peaked at $48.8K in Q4 2024.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fedenia Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.